[{"AccountsPayableCurrent_0_Q1_USD":6733000.0,"OtherLiabilitiesCurrent_0_Q1_USD":1932000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":80079000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":39000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":47000.0,"StockRepurchasedAndRetiredDuringPeriodValue_1_Q1_USD":9024000.0,"StockRepurchasedAndRetiredDuringPeriodShares_1_Q1_shares":300000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":92000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":68811000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":231941.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q1_shares":3294956.0,"OtherAssetsNoncurrent_0_Q1_USD":51000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":277000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":1231000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":3769000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":221000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":776000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":663000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":85000.0,"AccruedIncomeTaxes_0_Q1_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1153000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":961000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":192000.0,"OperatingLeaseLiability_0_Q1_USD":1153000.0,"OperatingLeaseCost_1_Q1_USD":54000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":149000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":157000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":39000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":196000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":225000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":230000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":275000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":1302000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":47653000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":776000.0,"AccruedInsuranceCurrent_0_Q1_USD":1740000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":219000.0,"ShareBasedCompensation_1_Q1_USD":776000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":12371000.0,"PreferredStockValue_0_Q1_USD":null,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-16000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":59826000.0,"LiabilitiesCurrent_0_Q1_USD":12265000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":85812000.0,"Liabilities_0_Q1_USD":13226000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1838000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":2625000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-12157000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.79,"CommonStockSharesOutstanding_0_Q1_shares":20182382.0,"CommonStockSharesIssued_0_Q1_shares":20182382.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":80079000.0,"AssetsCurrent_0_Q1_USD":83598000.0,"Assets_0_Q1_USD":85812000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":3089310.0,"AdditionalPaidInCapital_0_Q1_USD":144165000.0,"CommonStockValue_0_Q1_USD":20000.0,"PaymentsForRepurchaseOfEquity_1_Q1_USD":9024000.0,"NetIncomeLoss_1_Q1_USD":-14911000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3519000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-14996000.0,"OperatingExpenses_1_Q1_USD":14996000.0,"InterestPaidNet_1_Q1_USD":3000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":16000.0,"CommonStockSharesAuthorized_0_Q1_shares":50000000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":3600000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":18968096.0,"StockholdersEquity_0_Q1_USD":72586000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-71599000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1010000.0,"ProfitLoss_1_Q1_USD":-14911000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":68811000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"PaymentsOfStockIssuanceCosts_1_Q1_USD":4789000.0,"Ticker":"BTAI","CIK":"1720893","name":"BIOXCEL THERAPEUTICS, INC.","OfficialName":"BioXcel Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"417746551.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200512"}]